JP2004501189A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004501189A5 JP2004501189A5 JP2002504991A JP2002504991A JP2004501189A5 JP 2004501189 A5 JP2004501189 A5 JP 2004501189A5 JP 2002504991 A JP2002504991 A JP 2002504991A JP 2002504991 A JP2002504991 A JP 2002504991A JP 2004501189 A5 JP2004501189 A5 JP 2004501189A5
- Authority
- JP
- Japan
- Prior art keywords
- aminomethyl
- sleep
- insomnia
- methyl
- cyclopentyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 description 5
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 4
- 206010022437 insomnia Diseases 0.000 description 4
- IUVMAUQEZFTTFB-YUMQZZPRSA-N Atagabalin Chemical compound C[C@H]1CC(CN)(CC(O)=O)C[C@@H]1C IUVMAUQEZFTTFB-YUMQZZPRSA-N 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- KKXFMWXZXDUYBF-BDAKNGLRSA-N (3s,5r)-3-(aminomethyl)-5-methyloctanoic acid Chemical compound CCC[C@@H](C)C[C@H](CN)CC(O)=O KKXFMWXZXDUYBF-BDAKNGLRSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 230000000147 hypnotic effect Effects 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 208000019116 sleep disease Diseases 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 238000009509 drug development Methods 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 239000003326 hypnotic agent Substances 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 208000020685 sleep-wake disease Diseases 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21417100P | 2000-06-26 | 2000-06-26 | |
| PCT/US2001/016343 WO2002000209A2 (en) | 2000-06-26 | 2001-05-18 | Gabapentin analogues for sleep disorders |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004501189A JP2004501189A (ja) | 2004-01-15 |
| JP2004501189A5 true JP2004501189A5 (https=) | 2006-06-22 |
| JP3909842B2 JP3909842B2 (ja) | 2007-04-25 |
Family
ID=22798045
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002504991A Expired - Fee Related JP3909842B2 (ja) | 2000-06-26 | 2001-05-18 | 睡眠障害のためのガバペンチン類似物 |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US7141606B2 (https=) |
| EP (1) | EP1296671B1 (https=) |
| JP (1) | JP3909842B2 (https=) |
| KR (1) | KR100785182B1 (https=) |
| CN (1) | CN1279900C (https=) |
| AT (1) | ATE390133T1 (https=) |
| AU (2) | AU2001264736B2 (https=) |
| BR (1) | BR0111913A (https=) |
| CA (1) | CA2414008C (https=) |
| CZ (1) | CZ20024110A3 (https=) |
| DE (1) | DE60133389T2 (https=) |
| DK (1) | DK1296671T3 (https=) |
| ES (1) | ES2300332T3 (https=) |
| HU (1) | HUP0300833A3 (https=) |
| IL (2) | IL152770A0 (https=) |
| MX (1) | MXPA02010668A (https=) |
| NZ (1) | NZ522480A (https=) |
| PL (1) | PL359872A1 (https=) |
| PT (1) | PT1296671E (https=) |
| SK (1) | SK17922002A3 (https=) |
| TW (1) | TWI298020B (https=) |
| WO (1) | WO2002000209A2 (https=) |
| ZA (1) | ZA200209418B (https=) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR0208922A (pt) | 2001-04-19 | 2004-04-20 | Warner Lambert Co | Aminoácidos bicìclicos ou tricìclicos fundidos |
| US8048917B2 (en) | 2005-04-06 | 2011-11-01 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
| CA2449729C (en) | 2001-06-11 | 2009-11-03 | Xenoport, Inc. | Prodrugs of gaba analogs, compositions and uses thereof |
| US6818787B2 (en) | 2001-06-11 | 2004-11-16 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
| AU2002345638A1 (en) | 2001-06-11 | 2002-12-23 | Xenoport, Inc. | Amino acid conjugates providing for sustained systemic concentrations of gaba analogues |
| US7186855B2 (en) | 2001-06-11 | 2007-03-06 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
| AU2002316231A1 (en) | 2002-02-19 | 2003-09-29 | Xenoport, Inc. | Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof |
| AU2003222033A1 (en) | 2002-03-20 | 2003-10-08 | Xenoport | Cyclic 1-(acyloxy)-alkyl prodrugs of gaba analogs, compositions and uses thereof |
| AU2003243180A1 (en) | 2002-05-17 | 2003-12-12 | Xenoport, Inc. | Amino acid conjugates providing for sustained systemic concentrations of gaba analogues |
| US7060727B2 (en) | 2002-12-11 | 2006-06-13 | Xenoport, Inc. | Prodrugs of fused GABA analogs, pharmaceutical compositions and uses thereof |
| KR100709159B1 (ko) * | 2002-12-13 | 2007-04-19 | 워너-램버트 캄파니 엘엘씨 | 섬유근육통 및 기타 관련 장애를 위한 가바펜틴 유사체 |
| CA2451267A1 (en) * | 2002-12-13 | 2004-06-13 | Warner-Lambert Company Llc | Pharmaceutical uses for alpha2delta ligands |
| EP1622603A4 (en) * | 2003-03-25 | 2010-03-24 | Kiel Lab Inc | GABAPENTINIC PHENOLIC ACID SALTS IN SOLID DOSAGE FORMS AND METHODS OF USE |
| KR20060119971A (ko) | 2003-09-11 | 2006-11-24 | 제노포트 인코포레이티드 | Ｇａｂａ 유사체의 전구약물을 이용한 요실금의 치료및/또는 예방 |
| NZ579515A (en) | 2003-09-17 | 2011-09-30 | Xenoport Inc | Treating or preventing restless legs syndrome using prodrugs of gaba analogs |
| SG147437A1 (en) | 2003-10-14 | 2008-11-28 | Xenoport Inc | Crystalline form of gamma-aminobutyric acid analog |
| JP4613031B2 (ja) * | 2004-05-06 | 2011-01-12 | エスエス製薬株式会社 | 催眠剤組成物 |
| JP2005325070A (ja) * | 2004-05-14 | 2005-11-24 | Ss Pharmaceut Co Ltd | 睡眠改善剤 |
| MX2007005306A (es) | 2004-11-04 | 2007-06-11 | Xenoport Inc | Formas de dosis oral de liberacion sostenida de la prodroga gabapentina. |
| AU2006262502A1 (en) | 2005-06-23 | 2007-01-04 | Emory Univerisity | Imaging agents |
| KR20070070307A (ko) * | 2005-08-24 | 2007-07-04 | 에스에스 세야쿠 가부시키 가이샤 | 수면 개선 의약 조성물 |
| AU2007222112A1 (en) * | 2006-03-06 | 2007-09-13 | Pfizer Products Inc. | Alpha-2-delta ligands for non-restorative sleep |
| EP2250148B1 (en) | 2008-01-25 | 2016-08-17 | XenoPort, Inc. | Crystalline form of calcium-salts of (3s)-aminomethyl-5-methyl-hexanoic acids and methods of use |
| ES2601852T3 (es) | 2008-01-25 | 2017-02-16 | Xenoport, Inc. | Forma cristalina de sales de calcio de ácidos (3S)-aminometil-5-metil-hexanoicos y métodos de uso |
| US7868043B2 (en) | 2008-01-25 | 2011-01-11 | Xenoport, Inc. | Mesophasic forms of (3S)-aminomethyl-5-methyl-hexanoic acid prodrugs and methods of use |
| ES2589915T3 (es) | 2008-10-08 | 2016-11-17 | Xgene Pharmaceutical Inc | Conjugados de GABA y métodos de utilización de los mismos |
| ES2758554T3 (es) | 2009-12-08 | 2020-05-05 | Univ Case Western Reserve | Aminoácidos gama para tratamiento de trastornos oculares |
| US9066853B2 (en) | 2013-01-15 | 2015-06-30 | Warsaw Orthopedic, Inc. | Clonidine compounds in a biodegradable fiber |
| CA2903000C (en) | 2013-01-28 | 2021-10-12 | Hector L. Lopez | Methods of improving tolerability, pharmacodynamics, and efficacy of .beta.-alanine and use therefor |
| EP3466427A4 (en) * | 2016-05-26 | 2020-02-05 | Amino Up Chemical Co., Ltd. | SLEEPING AGENT |
| CA3099775A1 (en) | 2018-05-14 | 2019-11-21 | Xgene Pharmaceutical Inc. | Process for making 1-(acyloxy)-alkyl-carabmate drug conjugates of naproxen and pregabalin |
| CN117776950B (zh) * | 2022-09-20 | 2025-12-23 | 中科中山药物创新研究院 | 一种γ-氨基丁酸衍生物、药物组合物和应用 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4087544A (en) * | 1974-12-21 | 1978-05-02 | Warner-Lambert Company | Treatment of cranial dysfunctions using novel cyclic amino acids |
| DE2460891C2 (de) * | 1974-12-21 | 1982-09-23 | Gödecke AG, 1000 Berlin | 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
| US5084479A (en) * | 1990-01-02 | 1992-01-28 | Warner-Lambert Company | Novel methods for treating neurodegenerative diseases |
| US6197819B1 (en) * | 1990-11-27 | 2001-03-06 | Northwestern University | Gamma amino butyric acid analogs and optical isomers |
| US5510381A (en) * | 1995-05-15 | 1996-04-23 | Warner-Lambert Company | Method of treatment of mania and bipolar disorder |
| DE19525598C2 (de) * | 1995-07-13 | 1997-09-25 | Max Planck Gesellschaft | Schlafmittel |
| US6020370A (en) * | 1996-03-14 | 2000-02-01 | Warner-Lambert Company | Bridged cyclic amino acids as pharmaceutical agents |
| US6372792B1 (en) * | 1996-04-26 | 2002-04-16 | Guy Chouinard | Method for treating anxiety, anxiety disorders and insomnia |
| HUP0004310A3 (en) * | 1997-10-27 | 2001-11-28 | Warner Lambert Co | Cyclic amino acids, and derivatives thereof and pharmaceutical compositions comprising the said compounds as active agents |
| JP2002520277A (ja) * | 1998-07-09 | 2002-07-09 | ワーナー−ランバート・カンパニー | 不眠症を治療する方法 |
| BR0011236A (pt) * | 1999-06-02 | 2002-03-05 | Warner Lambert Co | Amino heterociclos úteis como agentes farmacêuticos |
| HN2000000224A (es) * | 1999-10-20 | 2001-04-11 | Warner Lambert Co | Aminoacidos biciclicos como agentes farmaceuticos |
| WO2001042190A1 (en) * | 1999-12-08 | 2001-06-14 | Warner-Lambert Company | Method for the stereoselective synthesis of cyclic amino acids |
| GB9930083D0 (en) * | 1999-12-20 | 2000-02-09 | Glaxo Group Ltd | Medicaments |
-
2001
- 2001-05-18 PL PL35987201A patent/PL359872A1/xx not_active Application Discontinuation
- 2001-05-18 IL IL15277001A patent/IL152770A0/xx unknown
- 2001-05-18 AU AU2001264736A patent/AU2001264736B2/en not_active Ceased
- 2001-05-18 KR KR1020027017609A patent/KR100785182B1/ko not_active Expired - Fee Related
- 2001-05-18 AU AU6473601A patent/AU6473601A/xx active Pending
- 2001-05-18 ES ES01939192T patent/ES2300332T3/es not_active Expired - Lifetime
- 2001-05-18 EP EP01939192A patent/EP1296671B1/en not_active Expired - Lifetime
- 2001-05-18 CA CA2414008A patent/CA2414008C/en not_active Expired - Fee Related
- 2001-05-18 SK SK1792-2002A patent/SK17922002A3/sk not_active Application Discontinuation
- 2001-05-18 CZ CZ20024110A patent/CZ20024110A3/cs unknown
- 2001-05-18 CN CNB018110487A patent/CN1279900C/zh not_active Expired - Fee Related
- 2001-05-18 WO PCT/US2001/016343 patent/WO2002000209A2/en not_active Ceased
- 2001-05-18 MX MXPA02010668A patent/MXPA02010668A/es active IP Right Grant
- 2001-05-18 DK DK01939192T patent/DK1296671T3/da active
- 2001-05-18 AT AT01939192T patent/ATE390133T1/de not_active IP Right Cessation
- 2001-05-18 NZ NZ522480A patent/NZ522480A/en unknown
- 2001-05-18 JP JP2002504991A patent/JP3909842B2/ja not_active Expired - Fee Related
- 2001-05-18 US US10/297,827 patent/US7141606B2/en not_active Expired - Fee Related
- 2001-05-18 BR BR0111913-3A patent/BR0111913A/pt not_active Application Discontinuation
- 2001-05-18 PT PT01939192T patent/PT1296671E/pt unknown
- 2001-05-18 DE DE60133389T patent/DE60133389T2/de not_active Expired - Lifetime
- 2001-05-18 HU HU0300833A patent/HUP0300833A3/hu unknown
- 2001-06-19 TW TW090114841A patent/TWI298020B/zh not_active IP Right Cessation
-
2002
- 2002-11-11 IL IL152770A patent/IL152770A/en not_active IP Right Cessation
- 2002-11-19 ZA ZA200209418A patent/ZA200209418B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004501189A5 (https=) | ||
| JP3377525B2 (ja) | ４―ヒドロキシ酪酸誘導体 | |
| CN105120866B (zh) | 与毒性醛相关的疾病和治疗 | |
| RU2128160C1 (ru) | Трометаминная соль (+)-(s)-2-(3-бензоилфенил)пропионовой кислоты, способ ее получения, фармацевтическая композиция | |
| JP2004528307A5 (https=) | ||
| CN1129397A (zh) | 治疗眼炎的含3-苯甲酰基苯乙酸衍生物的局部给药组合物 | |
| CA2522738A1 (en) | Compounds for the treatment of metabolic disorders | |
| CA2521621A1 (en) | Compounds for the treatment of metabolic disorders | |
| EA200500583A1 (ru) | Ингибиторы белка-регулятора трансмембранной проводимости при муковисцидозе и их применение | |
| RU2006116889A (ru) | Производные n-гетероциклилметилбензамидов, их получение и их применение в терапии | |
| RU2005128501A (ru) | Соединение для лечения метаболических расстройств | |
| RU2003105885A (ru) | Ингибиторы клеточной адгезии, опосредованной альфа 4-интегринами | |
| RU2003133924A (ru) | Дейтерированные 3-пиперидиноэтилфенилкетоны, а также лекарственные средства, содержащие эти соединения | |
| WO2017012556A1 (zh) | 一种芳基丙酸类化合物及其制药用途 | |
| CA2521589A1 (en) | Compounds for the treatment of metabolic disorders | |
| KR890005031A (ko) | L-도파유도체 또는 그의 산부가염, 그의 제조방법 및 그의 용도 | |
| CN102093246A (zh) | 酯类化合物、其制备方法和应用 | |
| RU2004101229A (ru) | Дейтерированные n-и альфа-замещенные аминоалкилэфиры дифенилакоксиуксуной кислоты, а также лекарственные средства, содержащие эти соединения | |
| WO2005105066A2 (en) | Histone deacetylases inhibitors against hyperlipidaemias, atherosclerosis, cardiovascular diseases | |
| JPWO2012074069A1 (ja) | 新規化合物及びその医薬用途 | |
| RU2010148387A (ru) | Производное фенилпропионовой кислоты и его применение | |
| KR20160005356A (ko) | 방사선완화 약제학적 제형 | |
| CN116496205B (zh) | 一种卡瑞斯汀的盐及其用途 | |
| RU2004125609A (ru) | Комбинации альфа-2-дельта-лиганда с селективным ингибитором циклооксигеназы-2 | |
| TWI335220B (en) | Use of caffeic acid phenethyl ester for manufacturing a medicament for treating neurodegenerative and cardiovascular disorders |